Gland Pharma shares made a strong debut on BSE and NSE today. Its shares rose to as much as ₹1,850 on BSE, up 23% compared to issue price of ₹1,500. The pharma company’s initial public offer (IPO), which closed on November 11, was subscribed two times.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
